These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 7646310)

  • 1. [Remission of left ventricular hypertrophy with ramipril independently of blood pressure changes: the HYCAR study (cardiac hypertrophy and ramipril)].
    Lièvre M; Guéret P; Gayet C; Roudaut R; Delair S; Boissel JP
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():35-42. PubMed ID: 7646310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. HYCAR Study Group.
    Lièvre M; Guéret P; Gayet C; Roudaut R; Haugh MC; Delair S; Boissel JP
    Hypertension; 1995 Jan; 25(1):92-7. PubMed ID: 7843761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ramipril on left ventricular mass in normotensive hemodialysis patients.
    Yu WC; Lin YP; Lin IF; Chuang SY; Chen CH
    Am J Kidney Dis; 2006 Mar; 47(3):478-84. PubMed ID: 16490627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
    Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
    Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.
    Cağlar N; Dincer I
    Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1359-68. PubMed ID: 22288296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of postoperative blood pressure control on regression of left ventricular mass following valve replacement for aortic stenosis.
    Imanaka K; Kohmoto O; Nishimura S; Yokote Y; Kyo S
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):994-9. PubMed ID: 15896607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is reversal of left ventricular hypertrophy a priority in patients with hypertension?].
    Plouin PF
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():49-53. PubMed ID: 7646312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.
    Nielsen FS; Sato A; Ali S; Tarnow L; Smidt UM; Kastrup J; Parving HH
    Diabetes Care; 1998 May; 21(5):804-9. PubMed ID: 9589245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in left ventricular function and mass during serial investigations after valve replacement for aortic stenosis.
    Lund O; Erlandsen M
    J Heart Valve Dis; 2000 Jul; 9(4):583-93. PubMed ID: 10947054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy.
    Thürmann PA
    J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S33-6; discussion S41-3. PubMed ID: 10028952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the regression of left ventricular hypertrophy and the changes in circadian blood pressure after long-term treatment with enalapril in hypertensive patients.
    Horio T; Kohno M; Yasunari K; Murakawa K; Yokokawa K; Ikeda M; Fukui T; Kano H; Takeda T
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):177-82. PubMed ID: 8032577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activity and expression of the myocardial postreceptor adenylyl cyclase system in pressure overload hypertrophy in rat.
    Holmer SR; Bruckschlegel G; Schunkert H; Rataj DB; Kromer EP; Riegger GA
    Cardiovasc Res; 1996 May; 31(5):719-28. PubMed ID: 8763401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy regression: the LIVE trial.
    Sheridan DJ
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):541-3. PubMed ID: 12497780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass.
    Simpson HJ; Gandy SJ; Houston JG; Rajendra NS; Davies JI; Struthers AD
    Heart; 2010 Jan; 96(2):148-52. PubMed ID: 19858141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects on cardiac arrhythmias of antihypertensive therapy causing regression of left ventricular hypertrophy.
    Mayet J; Chapman N; Shahi M; Poulter NR; Cunningham DA; Dave S; Kooner J; Sever PS; Foale RA; Thom SA
    Am J Hypertens; 1997 Jun; 10(6):611-8. PubMed ID: 9194506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.